- Report
- October 2022
- 188 Pages
Global
From €3387EUR$3,570USD£2,847GBP
- Report
- September 2022
- 244 Pages
Global
From €3387EUR$3,570USD£2,847GBP
- Report
- April 2022
- 189 Pages
Global
From €3382EUR$3,565USD£2,843GBP
- Report
- March 2022
- 200 Pages
Global
From €3387EUR$3,570USD£2,847GBP
- Report
- February 2022
- 227 Pages
Global
From €3521EUR$3,712USD£2,961GBP
- Report
- August 2021
- 295 Pages
Global
From €3521EUR$3,712USD£2,961GBP
- Report
- July 2021
- 277 Pages
Global
From €3521EUR$3,712USD£2,961GBP
- Book
- November 2015
- 776 Pages
- Book
- August 2014
- 240 Pages
- Book
- January 2024
- 864 Pages
- Book
- December 2023
- 864 Pages
- Book
- April 2022
- 352 Pages
- Book
- January 2022
- 720 Pages
- Book
- February 2021
- 544 Pages
- Book
- October 2020
- 288 Pages
- Book
- April 2018
- 432 Pages
- Book
- November 2013
- 744 Pages
- Book
- August 2023
Global

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders.
Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more